470PSafety run-in evaluation of the phase I trial of trifluridine/tipiracil (FTD/TPI) in combination with oxaliplatin and a monoclonal antibody (bevacizumab or nivolumab) in patients (pts) with metastatic colorectal cancer (mCRC). (23rd October 2018) - Calvo Ferrandiz, A; Dahan, L; Hollebecque, A; Prager, G; Andre, T; Argiles Martinez, G; Bordonaro, R; Stein, A; Tortora, G; Leger, C; Amellal, N; Tabernero, J